NMOSD
Clinical trials for NMOSD explained in plain language.
Never miss a new study
Get alerted when new NMOSD trials appear
Sign up with your email to follow new studies for NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for NMOSD patients: drug aims to slash relapse rate
Disease control Not yet recruitingThis study tests a drug called ravulizumab in about 19 Chinese adults with a rare autoimmune disease called NMOSD. The goal is to see if it can reduce the number of disease attacks (relapses) and slow disability. Participants must have had at least one attack in the past year and…
Matched conditions: NMOSD
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New antibody treatment aims to stop severe NMOSD attacks in their tracks
Disease control Not yet recruitingThis study tests whether monoclonal antibodies can safely reduce disability during acute attacks of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that damages the optic nerves and spinal cord. Forty adults experiencing a recent attack will receive the …
Matched conditions: NMOSD
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Major trial to find best drug for rare autoimmune disease
Disease control Not yet recruitingThis study compares five FDA-approved drugs (rituximab, ravulizumab, inebilizumab, satralizumab, and eculizumab) to see which one works best to prevent relapses in people with NMOSD, a rare autoimmune condition that can cause vision loss and paralysis. About 160 adults who test p…
Matched conditions: NMOSD
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:40 UTC
-
Hormone clues in rare brain disease
Knowledge-focused Not yet recruitingThis study looks at sex hormone levels in 4,000 people with NMOSD, a rare autoimmune disease affecting the nerves and eyes. Researchers want to see if hormone changes are linked to the disease. Participants will give blood samples for testing. The goal is to learn more, not to te…
Matched conditions: NMOSD
Sponsor: Xiamen Hospital of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:50 UTC